Purinergic Signalling

Papers
(The H4-Index of Purinergic Signalling is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Ectonucleoside triphosphate diphosphohydrolases and ecto-5′-nucleotidase in purinergic signaling: how the field developed and where we are now46
Involvement of P2X7 receptors in chronic pain disorders35
Structural basis for the functional properties of the P2X7 receptor for extracellular ATP32
Antagonism of the ATP-gated P2X7 receptor: a potential therapeutic strategy for cancer32
Recommended tool compounds and drugs for blocking P2X and P2Y receptors27
Pannexin 1 as a driver of inflammation and ischemia–reperfusion injury25
Purinergic signalling in spinal pain processing23
A novel definition and treatment of hyperinflammation in COVID-19 based on purinergic signalling23
Purinergic modulation of the immune response to infections18
Pro- and anti-inflammatory macrophages express a sub-type specific purinergic receptor profile18
Autocrine and paracrine purinergic signaling in the most lethal types of cancer18
Antidepressant-like effect of guanosine involves activation of AMPA receptor and BDNF/TrkB signaling17
Targeting the purinergic pathway in breast cancer and its therapeutic applications16
Mechanisms of ATP release in pain: role of pannexin and connexin channels16
Purinergic signaling: a potential therapeutic target for depression and chronic pain16
Effect of the conditioned medium of mesenchymal stem cells on the expression levels of P2X4 and P2X7 purinergic receptors in the spinal cord of rats with neuropathic pain15
Effect of P2X purinergic receptors in tumor progression and as a potential target for anti-tumor therapy15
Exploration of the link between gut microbiota and purinergic signalling15
0.043619871139526